Abbott SonicForce clinical trial

Abbott cardiovascular devices: SonicForce IVL strategy after TECTONIC CAD results

Abbott’s SonicForce Heart Device Achieves 97% Procedural Success in TECTONIC CAD Clinical Trial

Megan Wood6 hours ago5 hours ago011 mins

Why Abbott cardiovascular devices strategy leans on SonicForce: TECTONIC CAD 30-day data for an investigational coronary IVL system, not yet approved.